Trial Profile
The Effects of Armodafinil (Nuvigil) on Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Dec 2018
Price :
$35
*
At a glance
- Drugs Armodafinil (Primary)
- Indications Fatigue; Sleep apnoea syndrome
- Focus Therapeutic Use
- 22 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jun 2015 New trial record